La influencia de la gestión organizativa en el tiempo puerta-aguja del tratamiento fibrinolítico

La influencia de la gestión organizativa en el tiempo puerta-aguja del tratamiento fibrinolítico

Resumen: Introducción: El tiempo puerta-aguja (TPA) es el principal indicador del proceso del código ictus (CI). Según la guía de 2018 de la American Heart Association/American Stroke Association, el objetivo TPA debe ser inferior a 45 minutos. Para conseguirlo son necesarios protocolos eficaces y...

Full description

Bibliographic Details
Main Authors:	M. Vicente-Pascual, A. Quilez, M.P. Gil, C. González-Mingot, D. Vázquez-Justes, G. Mauri-Capdevila, J. Sanahuja, C. García-Vázquez, F. Purroy
Format:	Article
Language:	Spanish
Published:	Elsevier España 2023-06-01
Series:	Neurología
Subjects:	Acute stroke Door-to-needle time Intravenous thrombolysis Organisational changes Protocols
Online Access:	http://www.sciencedirect.com/science/article/pii/S021348532030428X

Similar Items

Impacto en los tiempos puerta-aguja de un conjunto de medidas para optimizar la atención hospitalaria del código ictus
by: H. Tejada Meza, et al.
Published: (2023-04-01)

New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke
by: Zhou Y, et al.
Published: (2017-05-01)

Reducing intravenous thrombolysis delay in acute ischemic stroke through a quality improvement program in the emergency department
by: Guangxiong Yuan, et al.
Published: (2022-09-01)

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
by: Maren Hieber, et al.
Published: (2019-03-01)

Impact of Thrombolysis Time Metrics When Participating in National Stroke Center Construction Project
by: Cheng W, et al.
Published: (2023-11-01)

Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
by: Robert Mikulík, et al.
Published: (2022-05-01)

Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes
by: Demi Tran, et al.
Published: (2019-11-01)

Helsinki Stroke Model Is Transferrable With “Real-World” Resources and Reduced Stroke Thrombolysis Delay to 34 min in Christchurch
by: Teddy Y. Wu, et al.
Published: (2018-04-01)

Gender disparity versus equality in acute stroke: a Middle Eastern country hospital-based study
by: John George, et al.
Published: (2023-06-01)

Challenges in Timely Pharmacological Reperfusion Therapy of Acute ST-Elevation Myocardial Infarction Patients: A Cross-sectional Study
by: Prakriti Snehil, et al.
Published: (2021-09-01)

Temporal Trends of Intravenous Thrombolysis Utilization in Acute Ischemic Stroke in a Prospective Cohort From 1998 to 2019: Modeling Based on Joinpoint Regression
by: Verónica V. Olavarría, et al.
Published: (2022-04-01)

Tenecteplase Improves Door‐to‐Needle Time in Real‐World Acute Stroke Treatment
by: Jillian Hall, et al.
Published: (2021-11-01)

Improving door-to-reperfusion time in acute ischemic stroke during the COVID-19 pandemic: experience from a public comprehensive stroke center in Brazil
by: Marcelo Klu, et al.
Published: (2023-07-01)

Effects of Nursing Quality Improvement on Thrombolytic Therapy for Acute Ischemic Stroke
by: Zhuo Liu, et al.
Published: (2018-11-01)

Implementation of the Helsinki Model at West Tallinn Central Hospital
by: Katrin Gross-Paju, et al.
Published: (2022-08-01)

Pre-Hospital Delay in Acute Ischemic Stroke Care: Current Findings and Future Perspectives in a Tertiary Stroke Center from Romania—A Cross-Sectional Study
by: Elena Oana Terecoasă, et al.
Published: (2022-07-01)

The Need for Structured Strategies to Improve Stroke Care in a Rural Telestroke Network in Northern New South Wales, Australia: An Observational Study
by: Yumi Tomari Kashida, et al.
Published: (2021-04-01)

Distance Neurological Supervision Using Telestroke Does Not Increase Door-to-Needle Time in Acute Ischemic Stroke Management: The Experience of Two Regional Stroke Units
by: Radhika Sood, et al.
Published: (2021-03-01)

Impact of emergency department arrival time on door-to-needle time in patients with acute stroke
by: Latha Ganti, et al.
Published: (2023-03-01)

EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
by: T. V. Demin, et al.
Published: (2010-03-01)

Impact of ongoing intravenous thrombolysis until completion of endovascular treatment in large vessel occlusion stroke patients
by: Johannes Wischmann, et al.
Published: (2023-08-01)

Citología aspirativa con aguja fina transbroncoscópica en lesiones endobronquiales
by: Pedro Pablo Pino Alfonso, et al.

Abstract 1122‐000035: Is Age Critical in Determining Stroke Severity Within the Telestroke Network?
by: Cassie A Simmons, et al.
Published: (2021-11-01)

Orolingual Angioedema After Intravenous Tissue Plasminogen Activator in a Patient with Insular Cortex Ischemia: A Case Report
by: Aydın Talip Yıldoğan, et al.
Published: (2020-12-01)

Experience in using intravenous thrombolysis in ischemic stroke in Tatarstan
by: D. R. Khasanova, et al.
Published: (2011-03-01)

Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit
by: Laurien S. Kuhrij, et al.
Published: (2019-11-01)

Intravenous Thrombolysis for a Stroke Mimic Patient
by: Lilly Nguyen, et al.
Published: (2021-10-01)

Fibrinolytic therapy in CCU instead of emergency ward: how it affects door to needle time?
by: Fatemeh Zeraati, et al.
Published: (2014-01-01)

Impact of improved stroke green channel process on the delay of intravenous thrombolysis in patients with acute cerebral infarction during the COVID-19 pandemic: An observational study
by: Qiwei Wang, et al.
Published: (2022-09-01)

Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke
by: Hongfei Li, et al.
Published: (2022-04-01)

Paradigm Shift for Thrombolysis for Patients with Acute Ischaemic Stroke, from Extension of the Time Window to the Rapid Recanalisation After Symptom Onset
by: Hye Seon Jeong, et al.
Published: (2017-06-01)

Quality indicators of intravenous thrombolysis from North India
by: Akanksha Grace William, et al.
Published: (2017-01-01)

First intravenous thrombolysis for pCys194Arg Notch 3 mutation in a Moroccan CADASIL patient with stroke
by: Mohamed Amine Mnaili, MD
Published: (2024-06-01)

Intravenous thrombolysis for acute ischemic stroke associated with known left ventricular thrombus: safe or not?
by: Sofia Kitmeridou, et al.
Published: (2022-12-01)

Thrombolytic therapy for ischemic stroke
by: Natalia Vyacheslavovna Pizova
Published: (2013-11-01)

Management of acute stroke
by: Ashok Vardhan Reddy Taallapalli, et al.
Published: (2022-01-01)

Factors Associated with Unfavorable Functional Outcomes After Intravenous Thrombolysis in Patients with Acute Ischemic Stroke
by: Satumanatpan N, et al.
Published: (2022-03-01)

Effect of cerebral microbleeds on hemorrhagic transformation and functional prognosis after intravenous thrombolysis of cerebral infarction
by: Jinli Chen, et al.
Published: (2022-09-01)

Intravenous Thrombolysis in a Stroke Patient Receiving Rivaroxaban
by: Felix Fluri, et al.
Published: (2013-10-01)

First experience with intravenous thrombolysis in ischemic stroke in Serbia
by: Jovanović Dejana, et al.
Published: (2007-01-01)